Early treatment with baloxavir marboxil in high-risk adolescent and adult outpatients with uncomplicated influenza (CAPSTONE-2): a randomised, placebo-controlled, phase 3 trial
Authors:
- 1 October 2020
- journal article
- research article
- Published by Elsevier in The Lancet Infectious Diseases
- Vol. 20 (10) , 1204-1214
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- A Prospective Intervention Study on Higher-Dose Oseltamivir Treatment in Adults Hospitalized With Influenza A and B InfectionsClinical Infectious Diseases, 2013
- Antivirals for Treatment of InfluenzaAnnals of Internal Medicine, 2012
- Oseltamivir and Risk of Lower Respiratory Tract Complications in Patients With Flu Symptoms: A Meta-analysis of Eleven Randomized Clinical TrialsClinical Infectious Diseases, 2011
- The Influence of Oseltamivir Treatment on the Risk of Stroke after Influenza InfectionCardiology, 2008
- The annual impact of seasonal influenza in the US: Measuring disease burden and costsVaccine, 2007
- Lower Clinical Effectiveness of Oseltamivir against Influenza B Contrasted with Influenza A Infection in ChildrenClinical Infectious Diseases, 2007
- A Comparison of the Effectiveness of Oseltamivir for the Treatment of Influenza A and Influenza B: A Japanese Multicenter Study of the 2003-2004 and 2004-2005 Influenza SeasonsClinical Infectious Diseases, 2006
- Impact of Oseltamivir Treatment on Influenza-Related Lower Respiratory Tract Complications and HospitalizationsArchives of internal medicine (1960), 2003
- Zanamivir for the Treatment of Influenza A and B Infection in High-Risk PatientsArchives of internal medicine (1960), 2001
- Efficacy and Safety of Inhaled Zanamivir for the Treatment of Influenza in Patients with Asthma or Chronic Obstructive Pulmonary DiseaseClinical Drug Investigation, 2000